BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
414 results:

  • 1. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
    Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
    Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma.
    Du W; Xia X; Gou Q; Xie Y; Gao L
    Asian J Surg; 2024 May; 47(5):2106-2121. PubMed ID: 38320907
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic role of PD-L1 expression in head and neck squamous cell carcinoma: An institutional experience from India.
    Kala PS; Thapliyal N; Pant B; Sharma N; Pandey HS
    Pathol Res Pract; 2024 Feb; 254():155133. PubMed ID: 38306860
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Relation of Langerhans cell size to buccal carcinoma.
    Mathew JKK; Gaikwad P; Pandian RMK; Rebekah G; Rabi S
    Biotech Histochem; 2024 Feb; 99(2):84-91. PubMed ID: 38293759
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
    Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
    ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
    Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
    J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel tetrahydrocurcumin integrated mucoadhesive nanocomposite κ-carrageenan/xanthan gum sponges: a strategy for effective local treatment of oral cancerous and precancerous lesions.
    Elbanna SA; Ebada HMK; Abdallah OY; Essawy MM; Abdelhamid HM; Barakat HS
    Drug Deliv; 2023 Dec; 30(1):2254530. PubMed ID: 37668361
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review.
    Baudouin R; Hans S; Lisan Q; Morin B; Adimi Y; Martin J; Lechien JR; Tartour E; Badoual C
    Laryngoscope; 2024 Apr; 134(4):1507-1516. PubMed ID: 37642393
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues.
    Chatterjee A; Chaudhary A; Ghosh A; Arun P; Mukherjee G; Arun I; Maitra A; Biswas N; Majumder PP
    Cancer Med; 2023 Aug; 12(16):16774-16787. PubMed ID: 37392167
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
    Takano EA; Younes MM; Meehan K; Spalding L; Yan M; Allan P; Fox SB; Redfern A; Clouston D; Giles GG; Christie EL; Anderson RL; Zethoven M; Phillips KA; Gorringe K; Britt KL
    BMC Cancer; 2023 May; 23(1):459. PubMed ID: 37208678
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
    Hue J; Valinciute Z; Thavaraj S; Veschini L
    Oral Oncol; 2023 Jun; 141():106399. PubMed ID: 37098302
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Expression of
    Zhang P; Zhao Y; Xia X; Mei S; Huang Y; Zhu Y; Yu S; Chen X
    Oncoimmunology; 2023; 12(1):2203073. PubMed ID: 37089448
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
    Huang Q; Li F; Ji M; Lin L; Hu C
    BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
    Casarotto M; Lupato V; Giurato G; Guerrieri R; Sulfaro S; Salvati A; D'Angelo E; Furlan C; Menegaldo A; Baboci L; Montico B; Turturici I; Dolcetti R; Romeo S; Baggio V; Corrado S; Businello G; Guido M; Weisz A; Giacomarra V; Franchin G; Steffan A; Sigalotti L; Vaccher E; Boscolo-Rizzo P; Jerry P; Fanetti G; Fratta E
    Clin Epigenetics; 2022 Dec; 14(1):171. PubMed ID: 36503584
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
    Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B
    Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
    Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Lauriola L; Ranelletti FO
    BMC Cancer; 2022 Jun; 22(1):704. PubMed ID: 35761298
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and clinical outcomes in head and neck cancer.
    Mattoscio D; Ferri G; Miccolo C; Chiocca S; Romano M; Recchiuti A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742918
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for head and neck cancer Treated with BNCT.
    Perotti Bernardini GF; Bortolussi S; Koivunoro H; Provenzano L; Ferrari C; Cansolino L; Postuma I; Carando DG; Kankaanranta L; Joensuu H; González SJ
    Radiat Res; 2022 Aug; 198(2):134-144. PubMed ID: 35504003
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
    Doll C; Steffen C; Beck-Broichsitter B; Richter M; Neumann K; Pohrt A; Lohneis P; Lehmann A; Heiland M; Stromberger C; Coordes A; Johrens K; Raguse JD
    Anticancer Res; 2022 May; 42(5):2405-2413. PubMed ID: 35489745
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.
    de Ruiter EJ; Bisheshar SK; de Roest RH; Wesseling FWR; Hoebers FJP; van den Hout MFCM; Leemans CR; Brakenhoff RH; de Bree R; Terhaard CHJ; Willems SM
    Virchows Arch; 2022 Aug; 481(2):223-231. PubMed ID: 35451620
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 21.